
Novel highly селективный SGK1 ингибитор with a highly optimized profile suitable for oral dosing as a potentially disease-modifying agent for osteoarthritis
Novel highly selective SGK1 inhibitor with a highly optimized profile suitable for oral dosing as a potentially disease-modifying agent for osteoarthritis
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.